Trademark Overview
On Friday, September 4, 2015, a trademark application was filed for NAZALONE with the United States Patent and Trademark Office. The USPTO has given the NAZALONE trademark a serial number of 86748246. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, May 10, 2016. This trademark is owned by Amphastar Pharmaceuticals, Inc.. The NAZALONE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical and drug preparations for use in treatment of opioid overdose and addiction; Medicinal preparations for use in treatment of opioid overdose and addiction; Pharmaceutical and drug preparations for the treatment of substance use disorders, addiction, and overdose; Medicinal preparations for the treatment of substance use disorders, addiction, and overdose; Pharmaceutical preparations, namely, opioid antagonists; pharmaceutical preparations, namely, pharmaceuticals which contain the compound naloxone; Pharmaceutical and drug preparations for use in complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics